SEC Form 4 · accession 0001076542-17-000085
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kent J. George
Director
Period of report
Jul 1, 2017
Accepted (ET)
Oct 5, 2017 · 11:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $1.00 | Jul 1, 2017 | J | 12,500 | A | Jul 1, 2017 | Jul 1, 2021 | Common Stock | 12,500 | 25,000 | D |
Explanation of responses
- F1Pursuant to the Director Services Agreement entered into between the Company and Mr. George, at the end of each three (3) month period that Director serves as a Director of the Company, the Company will grant to Director an option (each "an Option") to purchase 12,500 shares of the Company's restricted Common Stock, at a price equal to One Dollar ($1.00) per share or in the alternative the price per share (the "Strike Price") of the Company's then current 409a valuation. Once established the Strike Price shall remain effective for any and all Options granted as a result of being a Director until there is a change in any future 409a valuation. Such 409a valuations shall not be retroactive for options previously granted to the Director. The term of each Option shall be for a period of four (4) years from the date of issue of each Option.